Researcher Profile
Kim, Tae-Don(김태돈)
148
Center for Gene & Cell Theraphy (유전자 세포치료 전략연구단)
- Tel042-860-4236
- Research Area
- Technology
- Research Keywords
- Rna ; Gene therapy ; Cancer immunotherapy
- Rna ; 유전자치료제 ; 항암 면역세포치료제
Keywords Cloud
KRIBB Co-Working
Results 1-20 of 148 (Search time: 0.002 seconds).
| No. | Year | Title | Type |
|---|---|---|---|
| 148 | 2025 | 2025Patent 신규한 항-EphA2 키메릭 항원 수용체 및 이를 발현하는 면역세포JP2024-507172 (2024.02.02) / 7726496 (2025.08.12)김태돈; 이수연 |
Patent |
| 147 | 2025 | 2025Patent 신규한 항-CD5 키메릭 항원 수용체 및 이를 발현하는 면역세포JP2023-566973 (2023.10.30) / 7716500 (2025.07.23)김태돈; 조선아; 이수연 |
Patent |
| 146 | 2025 | 2025Patent 신규한 항-CD5 키메릭 항원 수용체 및 이를 발현하는 면역세포KR10-2022-0052018 (2022.04.27) / 10-2831183 (2025.07.03)김태돈; 조선아; 이수연 |
Patent |
| 145 | 2025 | Report | |
| 144 | 2025 | Report | |
| 143 | 2025 | 2025Article Dynamic O-GlcNAcylation governs long-range chromatin interactions in V(D)J recombination during early B-cell developmentCellular & Molecular Immunology, vol. 22, no. 1, pp. 68-82Bong Chan Jeon; Yu Ji Kim; A K Park; Mi-Ran Song; Ki Myeong Na; J Lee; D An; Y Park; H Hwang; Tae-Don Kim, et al. |
Article |
| 142 | 2025 | 2025Article Transcriptomic landscapes of STING-mediated DNA-sensing reveal cellular response heterogeneityInternational Journal of Biological Macromolecules, vol. 288, pp. 138752-138752Ling-Zu Kong; In-Hwan Jang; Chunli Wang; Soo Yun Lee; Seok-Min Kim; Se-Chan Oh; Sunyoung Lee; Seona Jo; Ji Hyun Kim; K K Kim, et al. |
Article |
| 141 | 2025 | 2025Article Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatmentFrontiers in Immunology, vol. 16, pp. 1448438-1448438Seok-Min Kim; Soo Yun Lee; S I Kim; J Y Bae; J T Hong; Seona Jo; Ji Hyun Kim; H Y Chung; Tae-Don Kim |
Article |
| 140 | 2025 | 2025Article Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancerCancer Immunology Immunotherapy, vol. 74, no. 2, pp. 73-73J Lee; J Song; Wonbeak Yoo; Hyunji Choi; D Jung; E Choi; S G Jo; E Y Gong; Y H Jeoung; Y S Park, et al. |
Article |
| 139 | 2025 | 2025Article Therapeutic effects of TN13 peptide on acute respiratory distress syndrome and sepsis models in vivoJournal of Clinical Medicine, vol. 14, no. 6, pp. 1804-1804Jae-Eun Byun; Jae-Won Lee; Eun Ji Choi; Juhyun Lee; Seok Han Yun; Chan Ho Park; Hanna Kim; Mi Sun Kim; Suk Ran Yoon; Tae-Don Kim, et al. |
Article |
| 138 | 2025 | 2025Article Generation and characterization of induced pluripotent stem cell derived from cynomolgus monkey (cmESF-iPS-C4)Stem Cell Research, vol. 87, pp. 103799-103799Min-Tae Kim; Xing Zhen; Se-hee Choe; Eunsu Jeon; Tae-Don Kim; Sang Je Park; Jong-Hee Lee |
Article |
| 137 | 2025 | 2025Research Project 맞춤형 바이오 의약품 개발을 위한 바이오-리폼 플랫폼 구축 = Development of Bio-Reform Platform for Customized Biopharmaceuticals연구책임자 : 정주연 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
| 136 | 2025 | 2025Research Project 신규 면역간극 조절인자 NgR1을 통한 면역력 제어 기작 = Mechanism of immunity control via a novel class of immune synapse regulator NgR1연구책임자 : 김태돈 / 사업기간 : 2025.05.01 ~ 2026.04.30 |
Research Project |
| 135 | 2025 | 2025Research Project 첨단바이오의약 글로벌 리더십 확보를 위한 한영공동연구센터 설립과 협력연구책임자 : 김장환 / 사업기간 : 2025.04.01 ~ 2025.12.31 |
Research Project |
| 134 | 2025 | 2025Research Project CAR 도입 제조 플랫폼에 따른 항암면역세포치료제의 품질 평가기술 개발 연구연구책임자 : 김태돈 / 사업기간 : 2025.02.01 ~ 2025.12.31 |
Research Project |
| 133 | 2025 | 2025Research Project 면역미세환경 제어 기술 기반 난치암 치료 원천기술 개발 = Development of Therapeutic Technologies for Refractory Cancer Treatment Based on Immune Microenvironment Modulation연구책임자 : 조희준 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
| 132 | 2025 | 2025Research Project RNA 디자인 기반 유전자-세포치료제 개발연구책임자 : 김태돈 / 사업기간 : 2025.04.01 ~ 2025.12.31 |
Research Project |
| 131 | 2025 | 2025Research Project 신규 합성기술 기반 고효율 mRNA 백신 플랫폼 개발 = Development of mRNA vaccine platforms using novel synthetic molecular design연구책임자 : 김태돈 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
| 130 | 2025 | 2025Research Project 세포기반 유전자치료기술 개발연구책임자 : 김태돈 / 사업기간 : 2025.06.01 ~ 2026.05.31 |
Research Project |
| 129 | 2024 | 2024Report 난치성 간암 치료를 위한 항 GPC-3 CAR-NK 치료제 개발 = Development of anti-GPC-3 CAR-NK cells for the treatment of intractable liver cancer연구책임자 : 김태돈 / 주관부처 : 과학기술정보통신부김태돈; 이수연; 이선영 |
Report |